Ylitalo Antti
A5036271134- COVID-19 and healthcare impacts
- Acute Myocardial Infarction Research
- Cardiac Arrest and Resuscitation
- COVID-19 Clinical Research Studies
- Cardiac Imaging and Diagnostics
- Venous Thromboembolism Diagnosis and Management
- Mechanical Circulatory Support Devices
- Atrial Fibrillation Management and Outcomes
- Takotsubo Cardiomyopathy and Associated Phenomena
- Global Health Care Issues
- Cardiac pacing and defibrillation studies
- Trauma and Emergency Care Studies
- Cardiovascular Function and Risk Factors
- Cardiac Ischemia and Reperfusion
- Antiplatelet Therapy and Cardiovascular Diseases
- Sepsis Diagnosis and Treatment
- Cardiovascular Issues in Pregnancy
- Cardiac, Anesthesia and Surgical Outcomes
- Coronary Interventions and Diagnostics
- Chronic Obstructive Pulmonary Disease (COPD) Research
- Child and Adolescent Health
- Radiomics and Machine Learning in Medical Imaging
- Insurance, Mortality, Demography, Risk Management
- Health and Medical Research Impacts
- Pericarditis and Cardiac Tamponade
University of Turku
2025
Turku PET Centre
2020-2024
National University Hospital
2021
Azienda Ospedaliero Universitaria Ospedali Riuniti
2021
Universidade Federal de Pernambuco
2021
Complexo Hospitalario Universitario A Coruña
2020
Centre Hospitalier Universitaire de Poitiers
2020
Therapeutic Guidelines
2012
The initial data of the International Study on Acute Coronary Syndromes - ST Elevation Myocardial Infarction COVID-19 showed in Europe a remarkable reduction primary percutaneous coronary intervention procedures and higher in-hospital mortality during phase pandemic as compared with prepandemic period. aim current study was to provide final results registry, subsequently extended outside larger inclusion period (up June 2020) longer follow-up 30 days).This is retrospective multicentre...
Abstract Background It has been suggested the COVID pandemic may have indirectly affected treatment and outcome of STEMI patients, by avoidance or significant delays in contacting emergency system. No data reported on impact diabetes that was therefore aim current subanalysis conducted patients included International Study Acute Coronary Syndromes–ST Elevation Myocardial Infarction (ISACS-STEMI) COVID-19. Methods The ISACS-STEMI COVID-19 is a retrospective registry performed European centers...
The constraints in the management of patients with ST-segment elevation myocardial infarction (STEMI) during COVID-19 pandemic have been suggested to severely impacted mortality levels. aim current analysis is evaluate age-related effects on mechanical reperfusion and 30-day for STEMI within registry ISACS-STEMI COVID-19.This retrospective multicenter was performed high-volume PPCI centers four continents included undergoing March-June 2019 2020. Patients were divided according age (< or ≥75...
Concerns have been raised on a potential interaction between renin-angiotensin system inhibitors (RASI) and the susceptibility to coronavirus disease 2019 (COVID-19). No data so far reported prognostic impact of RASI in patients suffering from ST-elevation myocardial infarction (STEMI) during COVID-19 pandemic, which was aim present study. STEMI treated with primary percutaneous coronary intervention (PPCI) enrolled ISACS-STEMI registry were included sub-analysis divided according therapy at...
SARS-Cov-2 has been suggested to promote thrombotic complications and higher mortality. The aim of the present study was evaluate impact SARS-CoV-2 positivity on in-hospital outcome 30-day mortality in ST-segment elevation myocardial infarction (STEMI) patients undergoing primary percutaneous coronary intervention (PCI) enrolled International Survey Acute Coronary Syndromes Myocardial Infarction (ISACS-STEMI COVID-19 registry. 109 positive were compared with 2005 negative patients. Positive...
The so-called “smoking paradox”, conditioning lower mortality in smokers among STEMI patients, has seldom been addressed the settings of modern primary PCI protocols. ISACS−STEMI COVID-19 is a large-scale retrospective multicenter registry addressing in-hospital mortality, reperfusion, and 30-day patients era pandemic. Among 16,083 6819 (42.3%) were active smokers, 2099 (13.1%) previous 7165 (44.6%) non-smokers. Despite impaired preprocedural recanalization (p < 0.001), had significantly...
Abstract Background Chronic obstructive pulmonary disease (COPD) is projected to become the third cause of mortality worldwide. COPD shares several pathophysiological mechanisms with cardiovascular disease, especially atherosclerosis. However, no definite answers are available on prognostic role in setting ST elevation myocardial infarction (STEMI), during COVID-19 pandemic, among patients undergoing primary angioplasty, that therefore aim current study. Methods In ISACS-STEMI registry we...
Background: Hypertension is the most prevalent cardiovascular risk factor, with several detrimental effects on system. Contrasting results have been reported so far its prognostic role in patients admitted for ST-segment elevation myocardial infarction (STEMI). Therefore, we investigated impact of hypertension short-term mortality a large multicenter contemporary registry STEMI patients, including treated during COVID-19 pandemic. Methods: The ISACS-STEMI was retrospective that included...
During the coronavirus disease 2019 (COVID-19) pandemic, concerns have been arisen on use of renin-angiotensin system inhibitors (RASI) due to potentially increased expression Angiotensin-converting-enzyme (ACE)2 and patient's susceptibility SARS-CoV2 infection. Diabetes mellitus recognized favoring infection with consequent increase mortality in COVID-19. No data so far reported diabetic patients suffering from ST-elevation myocardial infarction (STEMI), a very high-risk population...
Several reports have demonstrated the impact of COVID-19 pandemic on management and outcome patients with ST-segment elevation myocardial infarction (STEMI). The aim current analysis is to investigate potential gender difference in effects mechanical reperfusion 30-day mortality for STEMI within ISACS-STEMI Registry. This retrospective multicenter registry was performed high-volume primary percutaneous coronary intervention (PPCI) centers four continents included undergoing PPCIs March-June...